Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Parkinson
AddedMar 31, 2024
UpdatedMay 31, 2026
David Parkinson

David Parkinson

Board Member, Refuge Biotechnologies

CrunchbaseLinkedIn

David Parkinson's Career

Refuge Biotechnologies
Refuge Biotechnologies

Menlo Park, CA, US

Board Member· Board
3SBio
3SBio

Shenyang, Liaoning, CN

Board Member· Board
Multiple Myeloma Research Foundation - Mmrf
Multiple Myeloma Research Foundation - Mmrf

Norwalk, CT, US

Board Member· Board
Zyngenia
Zyngenia

Gaithersburg, MD, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Parkinson's Career

Refuge Biotechnologies
Refuge Biotechnologies

Menlo Park, CA, US

Board Member· Board
3SBio
3SBio
Public$15M5.3k1993Shenyang, Liaoning, CN
Board Member· Board

Leadership at 3SBio

Jing LouJing LouBoard Member
Wei ZhangWei ZhangBoard Member
Liping XuLiping XuCo-Founder
Fanzhi HuangFanzhi HuangBoard Member
Bin HuangBin HuangBoard Member
Dongmei SuDongmei SuBoard Member

Similar to 3SBio

Innovent BiologicsInnovent BiologicsSuzhou, Jiangsu, CNAntibody Drugs, Pharmaceuticalsest. 2011Innovent BiologicsSuzhou, Jiangsu, CN · est. 2011

Innovent Biologics, a Chinese biopharmaceutical firm, develops and distributes monoclonal antibody drugs for various diseases.

Public · $3B5.6k
Sinovac BiotechSinovac BiotechBeijing, Beijing, CNVaccinesest. 2001Sinovac BiotechBeijing, Beijing, CN · est. 2001

Sinovac Biotech Ltd., a Chinese firm, develops and markets vaccines globally, including flu and Hepatitis A.

Public · $96.3M750
Livzon MabpharmLivzon MabpharmZhuhai, Guangdong, CNAntibody Drugs, Pharmaceuticalsest. 2010Livzon MabpharmZhuhai, Guangdong, CN · est. 2010

China-based pharmaceutical company specializing in research, development, production, and sales of pharmaceutical products.

Public8.3k
Sino BiopharmaceuticalSino BiopharmaceuticalVictoria, Central and Western District, HKMedicine, Pharmaceuticalsest. 2000Sino BiopharmaceuticalVictoria, Central and Western District, HK · est. 2000

Sino Biopharmaceutical Ltd., a Chinese company specializing in the development and sale of medical treatments for ophthalmia and hepatitis.

Public25.6k
Multiple Myeloma Research Foundation - Mmrf
Multiple Myeloma Research Foundation - Mmrf
NonprofitNonprofit991998Norwalk, CT, US
Board Member· Board

Leadership at Multiple Myeloma Research Foundation - Mmrf

Karen AndrewsKaren AndrewsFounder
Kathy GiustiKathy GiustiBoard Member
Joel S. MarcusJoel S. MarcusBoard Member
Lori Tauber MarcusLori Tauber MarcusBoard Member
W Dana LaForgeW Dana LaForgeBoard Member
Michael AndreiniMichael AndreiniCEO

Similar to Multiple Myeloma Research Foundation - Mmrf

Leukemia & Lymphoma SocietyLeukemia & Lymphoma SocietyWhite Plains, NY, USCancer Research, Patient Supportest. 1944Leukemia & Lymphoma SocietyWhite Plains, NY, US · est. 1944

Global leader in blood cancer research, funding cures and treatments for patients.

Nonprofit750
National Foundation for Cancer ResearchNational Foundation for Cancer ResearchRockville, MD, USCancer Researchest. 1973National Foundation for Cancer ResearchRockville, MD, US · est. 1973

NFCR: A US nonprofit since 1973, funding cancer research for a cure.

Nonprofit39
National Multiple Sclerosis SocietyNational Multiple Sclerosis SocietyDenver, CO, USPatient Supportest. 1946National Multiple Sclerosis SocietyDenver, CO, US · est. 1946

US-based nonprofit advancing MS research and education to support patients.

Nonprofit7.5k
Cystic Fibrosis FoundationCystic Fibrosis FoundationNorth Bethesda, MD, USAdvocacy, Researchest. 1955Cystic Fibrosis FoundationNorth Bethesda, MD, US · est. 1955

US-based non-profit, Cystic Fibrosis Foundation, funds research to cure cystic fibrosis.

Nonprofit1.3k
Zyngenia
Zyngenia
Public$25M302008Gaithersburg, MD, US
Board Member· Board

Leadership at Zyngenia

Peter KienerPeter KienerBoard Member
Carlos BarbasCarlos BarbasFounder
Christian ItinChristian ItinBoard Member
Robert GarlandRobert GarlandBoard Member
Jason P RhodesJason P RhodesBoard Member

David Parkinson's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · KakaoSong Ji-Ho 'DeanSong Ji-Ho 'DeanBoard Member · Kakao

People Similar to David Parkinson

Ronald GoldRonald GoldBoard Member · NJ BioEric DresselhuysEric DresselhuysBoard Member · HeliumTodd DaviauTodd DaviauBoard Member · University of South FloridaDavid R EpsteinDavid R EpsteinBoard Member · Valo HealthDaniel HendersonDaniel HendersonCo-Founder · PaxVaxDavid SteinbergDavid SteinbergBoard Member · Rectify Pharmaceuticals